ArticleTherapeutics and clinical risk management2021

More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features.

Marko Lucijanic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.